3Lewis JF, Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol, 2003,65 : 613-642.
4Schurch S,Bachofen H,Goerke J,et al.A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. Appl Physiol, 1989,67(6) : 2389-2396.
5Schurch S, Bachofen H, Goerke J, et al. Surface properties of rat pulmonary surfactant studied with the captive bubble mothed: adsorption, hysteresis, stability. Biochim Biophys Acta, 1992,1103( 1 ) : 127-136.
6Taeusch HW. Treatment of acute (adult) respiratory distress syndrome: the holy grail of surfactant therapy. Biol Neonate,.2000,77 Suppl 1:2-8.
7Frerking I, Gtinther A, Seeger W, et al. Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med, 2001,27( 11 ) : 1699-1717.
8Taeusch HW,Lu KW,Goerke J,et al.Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med, 1999,159 (5 Pt 1):1391-1395.
